Hans-Henrik M. Dahl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hans-Henrik M. Dahl has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- David R. Thorburn
Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Australia
2 shared publications Dominic Thyagarajan
Department of Neurology, Flinders Medical Centre, Bedford Park, Adelaide, South Australia 5042 Australia
2 shared publicationsSharon Lewis
Murdoch Childrens Research Institute, The Royal Childrens Hospital, Parkville, Victoria 3052, Australia
2 shared publicationsWendy Hutchison
Murdoch Childrens Research Institute, The Royal Childrens Hospital, Parkville, Victoria 3052, Australia
2 shared publicationsA H Osborn
1 shared publicationAmelia H Osborn
Murdoch Children's Research Institute, Victorian Clinical Genetics Service, and Department of PaediatricsUniversity of Melbourne, Royal Children's HospitalMelbourneVIC
1 shared publication
Latest Publications
- 15 August 2003
- Published by S. Karger AG in Audiology and Neurotology
- Vol. 8 (5) , 263-268
Language and Speech Perception Outcomes in Hearing-Impaired Children with and without Connexin 26 Mutations
This study addressed the question of whether a hearing loss caused by mutations in the connexin 26 gene had a significant effect on language and speech perception outcomes in children using cochlear implants or hearing aids. The families of children who had participated in two previous studies of language development were invited to participate in this genetic study. From the 52 children whose families agreed to participate, 15 children with connexin 26 mutations in both chromosomes were identified. After taking into account other factors which are known to affect language development and speech perception in children with impaired hearing, no significant differences were found between the 15 children where connexin 26 was known to be the cause of deafness and the other 37 children in the study.
- 15 August 2003
- Published by S. Karger AG in Audiology and Neurotology
- Vol. 8 (5) , 263-268
Language and Speech Perception Outcomes in Hearing-Impaired Children with and without Connexin 26 Mutations
This study addressed the question of whether a hearing loss caused by mutations in the connexin 26 gene had a significant effect on language and speech perception outcomes in children using cochlear implants or hearing aids. The families of children who had participated in two previous studies of language development were invited to participate in this genetic study. From the 52 children whose families agreed to participate, 15 children with connexin 26 mutations in both chromosomes were identified. After taking into account other factors which are known to affect language development and speech perception in children with impaired hearing, no significant differences were found between the 15 children where connexin 26 was known to be the cause of deafness and the other 37 children in the study.
- 1 September 2002
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 201 (1-2) , 39-44
Clinical and molecular features of adPEO due to mutations in the Twinkle gene
- 1 September 2002
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 201 (1-2) , 39-44
Clinical and molecular features of adPEO due to mutations in the Twinkle gene
- 1 August 2001
- Published by AMPCo in Medical Journal of Australia
- Vol. 175 (4) , 191-194
Prevalence and nature of connexin 26 mutations in children with non‐syndromic deafness
To determine (1) the prevalence and nature of connexin 26 mutations in a cohort of Australian children with non-syndromic hearing loss, and (2) the carrier frequency of the common connexin 26 mutation (35delG) in the general population. A cohort, case-finding study. Mutation analysis was performed on DNA extracted from white blood cells, buccal cells, or Guthrie blood spots. A hearing loss investigation clinic and a deafness centre in two Australian capital cities, 1 January 1998 to 31 October 2000. (1) 243 children (age range, 4 weeks to 16 years; median, 4 years), attending hearing loss clinics in Sydney and Melbourne; (2) 1000 blood samples obtained from anonymous Guthrie card blood spots collected in 1984 [corrected] by the Victorian Clinical Genetics Service as part of the newborn screening program. (1) The prevalence and types of connexin 26 mutations in a cohort of children with prelingual deafness; (2) the carrier frequency of the common connexin 26 mutation, 35delG, in the general population. Connexin 26 mutations were identified and characterised in 52 (21%) of the 243 children; 14 different mutations, including four previously unreported mutations (135S, C53R, T123N and R127C), were identified. The common 35delG mutation was found in 56 of the 104 alleles (ie, 86 of the connexin 26 alleles in which a mutation was positively identified). The mutations V371 and M34T were also relatively common. The carrier frequency of connexin 26 mutations and of the common 35delG connexin 26 mutation in the Victorian population was estimated to be 1 in 54 and 1 in 100, respectively. Mutations in the connexin 26 gene (especially the 35delG mutation) are a common cause of prelingual hearing loss in Australia.
- 1 August 2001
- Published by AMPCo in Medical Journal of Australia
- Vol. 175 (4) , 191-194
Prevalence and nature of connexin 26 mutations in children with non‐syndromic deafness
To determine (1) the prevalence and nature of connexin 26 mutations in a cohort of Australian children with non-syndromic hearing loss, and (2) the carrier frequency of the common connexin 26 mutation (35delG) in the general population. A cohort, case-finding study. Mutation analysis was performed on DNA extracted from white blood cells, buccal cells, or Guthrie blood spots. A hearing loss investigation clinic and a deafness centre in two Australian capital cities, 1 January 1998 to 31 October 2000. (1) 243 children (age range, 4 weeks to 16 years; median, 4 years), attending hearing loss clinics in Sydney and Melbourne; (2) 1000 blood samples obtained from anonymous Guthrie card blood spots collected in 1984 [corrected] by the Victorian Clinical Genetics Service as part of the newborn screening program. (1) The prevalence and types of connexin 26 mutations in a cohort of children with prelingual deafness; (2) the carrier frequency of the common connexin 26 mutation, 35delG, in the general population. Connexin 26 mutations were identified and characterised in 52 (21%) of the 243 children; 14 different mutations, including four previously unreported mutations (135S, C53R, T123N and R127C), were identified. The common 35delG mutation was found in 56 of the 104 alleles (ie, 86 of the connexin 26 alleles in which a mutation was positively identified). The mutations V371 and M34T were also relatively common. The carrier frequency of connexin 26 mutations and of the common 35delG connexin 26 mutation in the Victorian population was estimated to be 1 in 54 and 1 in 100, respectively. Mutations in the connexin 26 gene (especially the 35delG mutation) are a common cause of prelingual hearing loss in Australia.
- Open Access
- 2 July 2001
- Published by Wiley in FEBS Letters
- Vol. 500 (3) , 183-185
Refinement of the adPEO linked locus on Chr10 and analysis of MRS4 and three other candidate genes
- 2 July 2001
- Published by Wiley in FEBS Letters
- Vol. 500 (3) , 183-185
Open AccessRefinement of the adPEO linked locus on Chr10 and analysis of MRS4 and three other candidate genes
- 1 March 2001
- Published by Wiley in American Journal of Medical Genetics
- Vol. 106 (1) , 1-3
Mitochondrial diseases: Beyond the magic circle
- 1 March 2001
- Published by Wiley in American Journal of Medical Genetics
- Vol. 106 (1) , 1-3
Mitochondrial diseases: Beyond the magic circle
- 31 December 2000
- Published by Elsevier in Molecular Diagnosis
- Vol. 5 (1) , 75-78
A simple PCR test to detect the common 35delG mutation in the connexin 26 gene
- 31 December 2000
- Published by Elsevier in Molecular Diagnosis
- Vol. 5 (1) , 75-78
A simple PCR test to detect the common 35delG mutation in the connexin 26 gene
- Open Access
- 1 July 2000
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 15 (suppl 2) , 246-255
Towards reliable prenatal diagnosis of mtDNA point mutations: studies of nt8993 mutations in oocytes, fetal tissues, children and adults
Prenatal diagnosis of mitochondrial DNA (mtDNA) mutations is technically possible, but has only rarely been attempted. This is largely because of uncertainty about the effects of mtDNA heteroplasmy, the mtDNA bottleneck, random segregation or selection of mtDNA species, and difficulty in correlating a particular mtDNA mutant load with clinical outcome. We have investigated the feasibility of prenatal diagnosis for two common mtDNA mutations at nucleotide (nt)8993 by determining mtDNA mutant loads in human oocytes and by reviewing data on 56 pedigrees with these mutations, and by reviewing six studies on mtDNA mutations in human fetuses. Data from heteroplasmic human and mouse oocytes demonstrate that the bottleneck occurs in early oogenesis. Analysis of mutant loads of the nt8993 mutations in fetal and adult tissues confirms that there is no substantial tissue variation, implying that the mutant load in a prenatal sample will represent the mutant load in other fetal tissues. The two nucleotide 8993 mutations each show a strong correlation between mutant load and symptom severity and between maternal blood mutant load and risk of a severe outcome. We generated empirical data for calculating recurrence risk and predicting the clinical outcome of a given mutant load. These predictive data can be used (cautiously) for genetic counselling and prenatal diagnosis of nucleotide 8993 mutations.
- 1 July 2000
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 15 (suppl 2) , 246-255
Open AccessTowards reliable prenatal diagnosis of mtDNA point mutations: studies of nt8993 mutations in oocytes, fetal tissues, children and adults
Prenatal diagnosis of mitochondrial DNA (mtDNA) mutations is technically possible, but has only rarely been attempted. This is largely because of uncertainty about the effects of mtDNA heteroplasmy, the mtDNA bottleneck, random segregation or selection of mtDNA species, and difficulty in correlating a particular mtDNA mutant load with clinical outcome. We have investigated the feasibility of prenatal diagnosis for two common mtDNA mutations at nucleotide (nt)8993 by determining mtDNA mutant loads in human oocytes and by reviewing data on 56 pedigrees with these mutations, and by reviewing six studies on mtDNA mutations in human fetuses. Data from heteroplasmic human and mouse oocytes demonstrate that the bottleneck occurs in early oogenesis. Analysis of mutant loads of the nt8993 mutations in fetal and adult tissues confirms that there is no substantial tissue variation, implying that the mutant load in a prenatal sample will represent the mutant load in other fetal tissues. The two nucleotide 8993 mutations each show a strong correlation between mutant load and symptom severity and between maternal blood mutant load and risk of a severe outcome. We generated empirical data for calculating recurrence risk and predicting the clinical outcome of a given mutant load. These predictive data can be used (cautiously) for genetic counselling and prenatal diagnosis of nucleotide 8993 mutations.
- 1 March 2000
- Published by Georg Thieme Verlag KG
- Vol. 5 (1) , 75-8
A simple PCR test to detect the common 35delG mutation in the connexin 26 gene.
The most common form of nonsyndromic neurosensory autosomal recessive deafness, DFNB1, is caused by mutations in the connexin 26 gene (GJB2) on chromosome 13. One mutation, in which one guanosine (G) residue is deleted from a run of 6 Gs (35delG), is found in 40% to 70% of DFNB1 cases and has an expected population frequency of one in 40 to one in 100. Polymerase chain reaction (PCR)-based tests for the 35delG mutation were developed. They are based on mismatched PCR primers that produce novel EcoRII or DdeI restriction enzyme sites depending on the number of Gs at the 35delG locus. An EcoRII site is generated in the wild-type sequence (6 Gs), but not when the 35delG mutation is present. Alternatively, a DdeI site can be generated so that this enzyme cuts the PCR product when the 35delG mutation is present, but not the wild-type sequence. These tests enable a quick and reliable screen for the common 35delG mutation.
- 1 March 2000
- Published by Georg Thieme Verlag KG
- Vol. 5 (1) , 75-8
A simple PCR test to detect the common 35delG mutation in the connexin 26 gene.
The most common form of nonsyndromic neurosensory autosomal recessive deafness, DFNB1, is caused by mutations in the connexin 26 gene (GJB2) on chromosome 13. One mutation, in which one guanosine (G) residue is deleted from a run of 6 Gs (35delG), is found in 40% to 70% of DFNB1 cases and has an expected population frequency of one in 40 to one in 100. Polymerase chain reaction (PCR)-based tests for the 35delG mutation were developed. They are based on mismatched PCR primers that produce novel EcoRII or DdeI restriction enzyme sites depending on the number of Gs at the 35delG locus. An EcoRII site is generated in the wild-type sequence (6 Gs), but not when the 35delG mutation is present. Alternatively, a DdeI site can be generated so that this enzyme cuts the PCR product when the 35delG mutation is present, but not the wild-type sequence. These tests enable a quick and reliable screen for the common 35delG mutation.
- 1 December 1998
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 63 (6) , 1594-1597
Getting to the Nucleus of Mitochondrial Disorders: Identification of Respiratory Chain–Enzyme Genes Causing Leigh Syndrome
- 1 December 1998
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 63 (6) , 1594-1597
Getting to the Nucleus of Mitochondrial Disorders: Identification of Respiratory Chain–Enzyme Genes Causing Leigh Syndrome
- 1 October 1995
- Published by Elsevier in Biochemical and Molecular Medicine
- Vol. 56 (1) , 26-30
mtDNA Deletion in a Patient with Symptoms of Mitochondrial Cytopathy but without Ragged Red Fibers
- 1 October 1995
- Published by Elsevier in Biochemical and Molecular Medicine
- Vol. 56 (1) , 26-30
mtDNA Deletion in a Patient with Symptoms of Mitochondrial Cytopathy but without Ragged Red Fibers